News & Updates
Showing Dermatology articles
Showing

Ustekinumab biosimilar SB17 boasts similar efficacy, safety in psoriasis
SB17, a proposed ustekinumab (UST) biosimilar, demonstrates comparable efficacy, safety, and pharmacokinetics (PK) to the reference drug, as well as lower immunogenicity up to week 28, among individuals suffering from moderate-to-severe psoriasis, according to a study.

Conservative excisional margin for small MIS tied to low recurrence
For small-sized melanoma in situ (MIS; <10 mm) on low-risk body sites, wide local excision (WLE) using a 5-mm margin was associated with a low rate of recurrence, a retrospective case series study has shown.

Tapinarof safe, efficacious for moderate-to-severe AD in children, adults
Treatment with tapinarof cream 1% once daily demonstrates significant efficacy with a favourable safety profile among adults and children with moderate-to-severe atopic dermatitis (AD), a study has shown.

Ongoing treatment required in severe patchy hair loss
For patients with severe alopecia areata who achieved meaningful hair regrowth with 1-year course of baricitinib, subsequent discontinuation appears to reverse treatment gains, highlighting the need for ongoing therapy.

Trans, saturated fat-heavy diets may trigger AD flares in Asians
High dietary consumption of trans fatty acids and saturated fatty acids appears to play some role in atopic dermatitis (AD) flare-ups among Chinese adults from Singapore and Malaysia, according to a large study.




